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Plasmacytoid dendritic cells (pDCs) are antigen presenting cells (APCs) specialized in viral 
recognition through Toll-like receptor (TLR)7 and TLR9, and produce vast amounts of 
interferon alpha (IFNα) upon ligation of these TLRs. We have previously demonstrated a 
strong influx of pDCs in the tubulointerstitium of renal biopsies at time of acute rejection. 
However, the role of human pDCs in mediating acute or chronic allograft rejection remains 
elusive. pDCs are thought to have a limited capacity to ingest apoptotic cells (ACs), which is 
critical for inducing CD4+ T cell activation via indirect antigen presentation and subsequent 
activation of antibody producing B cells. Here we set out to investigate whether the function 
of pDCs is affected by their presence within the graft. We show that maturation and IFNα 
production by pDCs was enhanced when cells were activated in the presence of viable HK2 
renal epithelial cells. Importantly, soluble factors produced by CMV-infected (primary) 
epithelial or endothelial cells enhanced pDC activation, and induced their capacity to 
phagocytose apoptotic cells. Phagocytosis was not induced by free virus or soluble factors 
from non-infected cells. Activated pDCs showed an enhanced CD4+ and CD8+ T cell 
allostimulatory capacity, as well as a potent indirect alloantigen presentation.We identified 
GM-CSF as one of the soluble factors produced by renal epithelial cells  that,  combined with 
TLR9 ligation, induced this functional capacity.  Our data suggest that pDCs present in the 
rejecting allograft can contribute to alloimmunity and can potentially act as important 
orchestrators in the manifestation of acute and chronic rejection. 
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Plasmacytoid dendritic cells (pDCs) were first classified as dendritic cells (DCs) in the 
1990s 1, and have since been shown to be capable of acting as antigen presenting cells 
(APCs) 1–3. pDCs selectively express the endosomal Toll-like receptor (TLR)7 and TLR9 4, 
which allows for the detection of viral and bacterial single stranded RNA and 
hypomethylated DNA respectively 5,6. Ligation of these TLRs leads to the production of vast 
amounts of interferon alpha (IFNα), and pDCs are hence referred to as the type I IFN 
producing cells. These abilities stage pDCs as APCs instrumental for the clearance of 
infections 7–9. However, pDCs can also express proteins involved in the induction of T cell 
tolerance, e.g. Indoleamine-pyrrole 2,3-dioxygenase (IDO), Delta-Like-4 , PD-L1 and 
Granzyme B 10–13. 
APCs are key in the manifestation of both acute and chronic rejection in solid organ 
transplantation. Passenger APCs of donor origin can induce allo-reactive T cell activation via 
the direct antigen (Ag) recognition pathway early after transplantation, whereas APCs of the 
recipient are involved in chronic rejection by mediating indirect Ag presentation 14. Although 
in theory any activated passenger APC can induce direct allo-reactivity, the induction of CD4+ 
T cells with indirect specificity requires the phagocytosis of donor cell-derived Ag, e.g. 
apoptotic cells, and subsequent presentation of the acquired Ag in the context of MHC class 
II by mature APCs.  
APC maturation can be induced by infections, via the recognition of pathogen-
associated molecular patterns by e.g. TLRs. Transplanted patients are susceptible to 
opportunistic infections due to their immune suppressed state, and especially infection with 
polyomaviruses (BK virus) and cytomegalovirus (CMV) causes morbidity and mortality 15. 
Interestingly, multiple studies have suggested a relation between infection (especially with 
CMV) and allograft rejection, despite remaining inconclusive due to the complexity of this 
interplay 16.  
Our laboratory has previously shown a strong influx of pDCs in the 
tubulointerstitium of renal biopsies taken at time of rejection, as compared to those taken at 
time of transplantation 17. As such, pDCs could be bridging infection and allograft loss 18. 
Despite these observations, the role of pDCs in the manifestation of solid organ rejection 
remains elusive. Experimental transplantation models have demonstrated that pDCs are 
capable of allo-Ag presentation 18–20. Moreover, an IFNα signature was shown clinically 
during chronic antibody-mediated rejection , which coincided with an increased number of 
pDCs within the graft 21. In addition, human pDCs are able to ingest antigen, e.g. virions, 
synthetic long peptides, and exosomes 22–24. However, data on the ability of pDCs to ingest 
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apoptotic cells (ACs) remains controversial, and hence their potential role in mediating 
chronic rejection. It has been suggested that pDCs can only phagocytose infected ACs 25,26, 
while other studies have demonstrated pDCs to have a very limited capacity to ingest ACs 27.  
Since we observed an influx of pDCs in renal tissue at time of rejection, we set out to 
assess whether human pDC biology, and especially phagocytosis, is affected by their 
presence in renal tissue, and whether viral infection alters this interaction. Here we 
demonstrate that TLR9 ligation of pDC in the presence of tissue cell-produced soluble 
factors, including GM-CSF, initiates pDC’s phagocytic capacity and strongly enhances their 
function. Our data position pDCs as APCs capable of mounting allogeneic immune responses 
via the indirect Ag presentation pathway, following activation by TLR9 ligation in the 




CpG-mediated pDC phenotypic maturation and IFNα production are enhanced 
following co-culture with renal epithelial cells 
Recently, we demonstrated a strong influx of pDCs in the tubulointerstitium of biopsies of 
patients with acute allograft rejection 17. Since pDCs were present in close proximity of the 
tubules, we investigated whether human kidney proximal tubular epithelial (HK2) cells could 
affect phenotypic maturation and IFNα production of purified blood-derived human pDCs.  
In absence of any activating stimuli, culturing pDCs alone, or in the presence of 
viable HK2 cells did not lead to clear alterations in phenotypic maturation (Fig. 1a) nor IFNα 
production (Fig. 1b). Mimicking infection by the addition of the synthetic TLR9 ligand CpG led 
to the upregulation of the co-stimulatory molecule CD86, as well as the co-inhibitory 
molecule PD-L1 (Fig. 1c). As expected, pDC activation by CpG led to a robust IFNα production 
(Fig. 1d). Interestingly, CpG activation of pDCs in the presence of viable HK2 cells led to a 
significant increase in the expression of the costimulatory molecules CD86 and CD83, which 
coincided with a markedly reduced increase in the expression of the co-inhibitory molecule 
PD-L1 (Fig. 1c, black bars), compared to pDCs activated alone (Fig. 1c, white bars). In 
addition, the production of IFNα was significantly increased when pDCs were activated in the 
presence of HK2 cells (Fig. 1d), whereas CpG treatment of HK2 cells alone did not result in 
measurable IFNα production (data not shown). These data demonstrate that the presence of 
HK2 cells enhances CpG-induced pDC activation.  
 To study the effect of genuine viral infection, we setup a model using a GFP-
expressing CMV strain. To this end, HK2 cells were infected with a varying multiplicity of 
infection (MOI). The infection efficiencies were CMV-dose-dependent, and the infection 
peak was observed 72 hours post infection (Fig. 1e) with a mean efficiency of 43% (range 
14% - 75%). 
 
pDC maturation and cytokine production is increased by conditioned medium of 
CMV-infected HK2 cells 
To address the effect of soluble factors produced by HK2 cell on pDCs, we harvested 
conditioned medium from non-infected HK2 (HCM) and CMV-infected HK2 cells (HCCM), and 
assessed the effect on pDC phenotypic maturation using flow cytometry (Fig. 2a). 
Quantification of the phenotypic analysis revealed that the expression of most activation 
markers remained low when pDCs were cultured in the presence of HCM for 48 hours. 
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However, following culture with HCCM the expression of CD40 (p = 0.058), CD86 (p = 0.005) 
and MHC II (p = 0.007) significantly increased (Fig 2b). 
Analysis of the cytokine production showed that most of the tested cytokines were 
unaffected or affected to a minor extent by culturing pDCs in the presence of HCM or HCCM 
(Fig. 2c and data not shown), as compared to untreated pDCs. However, the production of 
IL-12p70 and IFNα by pDCs was significantly increased by HCCM, as compared to culture 
conditions without any stimulation or HCM (Fig. 2c). The induction of pDC maturation could 
(in part) be the result of remaining CMV virions within HCCM. Indeed, CMV DNA could be 
detected in HCCM by PCR, as opposed to HCM, albeit at lower levels compared to the 
original infection medium (Fig. 2d). Although viral DNA was detected in HCCM, we were 
unable to directly infect pDCs with CMV, showing that the increased activation of pDCs by 
HCCM cannot be caused by pDC infection (data not shown). These data demonstrate that 
pDCs become phenotypically mature and produce pro-inflammatory cytokines following 
culture in the presence of conditioned medium of virally infected HK2 cells. 
 
Activation by HCCM initiates pDC phagocytic capacity and subsequent maturation 
pDCs are known to be able to act as APCs in transplantation models 18–20, which suggests 
they harbor the capacity to ingest donor antigen. Despite discrepancies in literature on the 
ability of pDCs to phagocytose ACs, consensus is that pDCs are capable of ingesting 
particulate antigen, but have a very limited capacity to ingest AC27. To investigate the effect 
of the conditioned media on pDC phagocytosis, we induced apoptosis by low-dose H2O2 in 
HK2 cells. pDCs were co-cultured overnight with fluorescently labeled AC in presence or 
absence of HCM or HCCM. The percentage of (BDCA-2POS/CD123POS) pDCs capable of 
phagocytosing AC was determined by analyzing the percentage of pDCs positive for CFSE 
using flow cytometry (Fig. 3a). In accordance with literature, pDCs showed a very limited 
capacity to ingest AC without stimulation (Fig. 3b). However, a robust increase in the 
phagocytic capacity of pDCs was achieved when AC were added in the presence of HCCM. In 
contrast, phagocytosis was not significantly increased in the presence of HCM, free CMV, or 
when using AC derived from CMV-infected HK2 cells (Fig 3b; HCCM, HCM, CMV, and ACCMV 
respectively). The phagocytosis induced by HCCM was an active process, since AC uptake 
was enhanced only when pDCs were cultured at 37 °C and not at 4 °C (Fig. 3c). To further 
confirm AC internalization, confocal microscopy was performed (Fig. 3d) and HLA-A2 
negative pDCs were cultured overnight with CFSE-labeled HLA-A2 positive AC (Fig. 3e upper 
histogram), after which CFSE and HLA-A2 positivity was determined on pDCs (Fig. 3e lower 
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plot). Only a minor portion (<1%) of pDCs were both CFSE and HLA-A2 positive, 
demonstrating that the larger portion of CFSE positivity (being AC) was internalized.  
Since DC maturation can be negatively affected by phagocytosis of AC 28,29, we 
analyzed pDC phenotype by flow cytometry following incubation with AC, and subsequently 
discriminating between pDCs which had (+) or had not (-) ingested AC (Fig. 3f). Whereas the 
expression of MHC class I and II was unaffected, pDCs which had ingested AC in fact showed 
an increased expression of CD40, CD80, CD83, CD86 and CCR7 (Fig.3f). 
 
HCCM-induced pDC phagocytosis is independent of the type of cell death or 
apoptotic cell source, and enhances indirect antigen presentation 
These data demonstrate that pDCs acquire the ability to become efficient phagocytes upon 
priming with soluble factors from CMV-infected HK2 cells. To address whether the type of 
apoptosis induction or AC source could affect the capacity of pDCs to ingest cell-derived 
material, we induced apoptosis in HK2 cells by means of UV- irradiation, or in endothelial 
cells (ECRF) by low-dose H2O2. AC derived from both UV-irradiated HK2 cells and from H2O2-
treated ECRF were efficiently phagocytosed by pDCs cultured in the presence of HCCM (Fig. 
4a). In addition, HCCM-activated pDCs were able to ingest necrotic cells, a process which 
was hampered when pDCs were kept at 4 °C (Fig. 4b). 
We next assessed whether the phagocytic capacity could also be induced by 
conditioned medium from other infected cell types. Whereas conditioned medium of non-
infected endothelial cells (ECM) could not, conditioned medium from CMV-infected 
endothelial cells (ECCM) induced the phagocytic capacity of pDCs (Fig. 4c). Likewise, 
conditioned medium from non-infected primary proximal tubular epithelial cells (PTEC) had 
a minor effect on phagocytosis, whereas conditioned medium of CMV-infected PTEC 
increased the phagocytosis significantly (Fig. 4d, p ≤ 0.05). 
Finally, using a CD4+ T cell clone with indirect specificity (T cell clone 4.44, which 
recognizes the aa101-114 epitope of HLA-A*201 in the context of HLA-DRB1*0101 30), we 
investigated the indirect alloantigen presenting capacity of pDCs. Different concentrations of 
the HLA-A*201 synthetic long peptide (SLP, aa91-120) were incubated with HLA-A2neg, HLA-
DR0101pos pDCs in the absence or presence of conditioned medium. After 24 hrs co-culture 
with T cell clone 4.44, the IFNγ production was determined as a measure for T cell activation 
resulting from indirect Ag presentation. HCCM-treated pDCs induced a more pronounced 
indirect Ag presentation, both in the magnitude of the IFNγ response and the SLP 




CD4+ and CD8+ T cell proliferation and T cell cytokine production is increased by 
HCCM-activated pDCs 
Next, we determined whether the maturation of pDCs induced by HCCM resulted in an 
altered ability to induce T cell activation. To this end we performed a mixed leucocyte 
reaction (MLR). pDCs were activated overnight, washed, and subsequently co-cultured with 
CFSE-labeled allogeneic peripheral blood lymphocytes at different ratios. After 5 days, T cell 
proliferation was assessed using flow cytometry, by determining the CFSE dilution of CD4+ 
and CD8+ T cells, by their respective gating within the viable (7AADNEG) T cell (CD3POS) 
population (Fig. 5a). As expected, culturing PBL with different ratios of pDCs resulted in a 
dose-dependent induction of proliferation (Fig. 5b). Quantification of the proliferation 
induced by non-activated pDCs showed a limited CD4+ and CD8+ T cell proliferation (Fig. 5c). 
Despite the lack of phenotypic maturation and minimal cytokine production (Fig. 2a-c), pDCs 
cultured overnight with HCM induced T cell proliferation to some degree (Fig. 5b-c). 
Interestingly, whereas CD8+ T cell proliferation was increased to a minor extent, overnight 
activation of pDCs with HCCM significantly enhanced their capacity to induce CD4+ T cell 
proliferation (Fig 5c).  
 Subsequent analysis of T cell cytokines showed that T helper cell (TH) cytokines were 
produced to some degree, with the exception of the TH2 cytokine IL-4 (Fig. 5d). The TH17 
cytokine IL-17 was produced at comparable levels, irrespective of the type of stimulus. In 
contrast, HCCM-activated pDCs strongly increased the production of TH1 cytokine IFNγ, 
compared to the response induced by non- or HCM-activated pDCs (Fig. 5d). The activation 
with HCCM also led to increased production IL-10, albeit at lower absolute levels compared 
to HCM.  
These data demonstrate that pDCs activated with HCCM induce significant CD4+ and 
CD8+ T cell proliferation, as well as a TH1 skewed cytokine profile. 
 
 Infection of HK2 cells is not a prerequisite for the induction of phagocytosis, but 
the combined activation by tissue-produced factors and TLR9 ligation is. 
To gain insight in the soluble factors produced, we analyzed HCM and HCCM by ELISA (IL-3 
and IFNα) and Luminex (Fig. 6a). Most of the tested cytokines/chemokines were not 
produced by HK2 cells, or were produced at low levels (Fig 6a, white bars), irrespective of 
CMV infection (Fig 6a, black bars). In contrast, HK2 cells produced large amounts of IL-6 and 
IL-8, and substantial levels of GM-CSF, G-CSF, MCP-1, TNFα  and IFNγ (Fig. 6a, white bars), 
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which were marginally increased following infection (Fig. 6a, black bars). Importantly, we 
were unable to detect the pDC survival factors IL-3 and IFNα in either conditioned medium.  
 Since we observed a minor difference in the analyzed factors between HCM and 
HCCM, we next determined whether viral infection of HK2 was indeed required for the 
induction of phagocytosis. pDCs that were cultured with AC from CMV-infected cells (ACCMV) 
or with non-infected AC in the presence of CpG, or HCM did not significantly increase their 
phagocytosis (Fig. 6b). In contrast, HCCM clearly enhanced phagocytosis, which could be 
slightly increased by the addition of ACCMV or CpG. Importantly, combining HCM with either 
ACCMV or with CpG also led to a strong increase in phagocytosis, mimicking the effect 
observed with HCCM. In addition to the HK2 cell line, supplementation of CpG to 
conditioned medium of primary PTECs also led to a marked increase in phagocytosis (Fig. 
6c). These data show that the induction of phagocytosis is the result of the combined 
activation of (a) soluble factor(s) and TLR9 ligand (i.e. ACCMV or CpG). 
 To determine whether one of the detected cytokines was responsible for this 
phenotype, we supplemented recombinant cytokines to pDC culture medium, either alone 
or combined with CpG. None of the added cytokines affected phagocytosis, with the 
exception of GM-CSF, which significantly enhanced phagocytosis. Importantly, this effect 
was only observed when GM-CSF was combined with CpG (Fig. 6d). In order to confirm GM-
CSF was indeed the driving factor within the conditioned medium, we targeted GM-CSF 
using a neutralizing antibody. We first assessed the effectiveness of the antibody by 
neutralizing GM-CSF in culture medium which was supplemented with recombinant GM-CSF 
and CpG. Whereas the induction of phagocytosis was unaffected by the addition of an 
isotype antibody, targeting GM-CSF abrogated the increased phagocytosis induced by 
recombinant GM-CSF (Fig. 6e, recGM-CSF). Despite a consequent reduction, we could not 
fully abrogate phagocytosis by neutralizing GM-CSF in HCM (Fig. 6e, HCM), despite the fact 
that the mean GM-CSF concentration in HCM was 172 pg/mL, compared to 500 pg/mL for 
recombinant GM-CSF. These data suggest that, next to GM-CSF, (an) additional factor(s) is 






Here, we demonstrate that TLR9 ligation of pDCs in the presence of conditioned medium of 
renal epithelial cells initiates their phagocytic capacity, and enhances antigen presentation 
and T cell activation. We identified GM-CSF as an active compound driving this process, 
although additional, currently unknown, factors are of importance within the conditioned 
medium.  Importantly, the induction of phagocytosis was critically dependent on TLR9 
ligation. Within the limitation of being an in vitro study, our data demonstrates that pDCs 
can aid in orchestrating allo-reactive immune responses. This is in line with our previous 
data, showing a strong influx of pDCs in the tubulointerstitium in renal biopsies at time of 
acute rejection 17.  
In the current study we used a GFP-tagged CMV strain to infect HK2 epithelial cells. 
Although CMV does not typically infect epithelial cells, whereas BK virus does, both viruses 
are able to ligate TLR9 31. The presence of the GFP tag in the used CMV strain allowed for the 
assessment of the infection efficiency. Our data demonstrates that pDCs become mature 
APC by activation with conditioned medium of CMV-infected HK2 cells (HCCM). We showed 
that viral DNA is present in HCCM, the presence of CMV cannot explain the induction of the 
phagocytic capacity in pDCs. We demonstrated that neither free virus, nor AC derived from 
CMV-infected cells, can induce phagocytosis as robust as HCCM. In line with this observation 
we showed that phagocytosis was only induced by TLR9 ligation in the presence of 
conditioned medium or GM-CSF.  
The capacity to phagocytose AC can have important implications for the capacity of indirect 
antigen presentation, and, although this was not proven directly, we could indeed show an 
increase in indirect alloantigen presentation using a model system with an indirectly-reactive 
CD4+ T cell clone and a synthetic long peptide. Moreover, using an MLR we demonstrated 
that HCCM-activated pDCs displayed an increased capacity to induce T cell priming and TH1 
skewing. The production of IFNα and low levels of IL-12p70 by HCCM-activated pDCs could 
be driving the TH1 polarization we observed in the MLR. The latter is instrumental for the 
potent induction of antigen-specific CD8+ cytotoxic T cells, which are important for the 
clearance of virally-infected cells. Moreover, combined with the production of IFNα, CD4+ T 
cell activation is the driving force for antibody production by B cells 32, and this can explain 
the recently observed IFNα signature in PBMCs during chronic antibody-mediated rejection, 
which coincided with an increased number of pDCs within the graft 21. These data further 
support the notion that, as the natural type I IFN producing cells, pDC could have an 
important role in mediating renal allograft rejection. 
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Whether GM-CSF and other soluble factors are secreted at higher levels following 
CMV infection in vivo remains to be determined. It is established that RIG-I-like receptors, as 
well as TLR7 and TLR9, are capable of detecting (cytosolic/endosomal) nucleic acids 33,34, and 
epithelial cells should therefore be able to detect early CMV infection 35. Following viral 
sensing, infected cells produce IFNs 36 which could coincide with the secretion of aditional 
soluble factors. Recruited pDCs can subsequently become primed for phagocytosis and 
initiate an anti-viral response. In the context of transplantation, this can directly impact 
allogeneic immunity by potentially activating T cells with indirect specificity. To determine 
the in vivo relevance of pDCs in inducing alloimmunity, future studies should include the 
examination of the in situ activation status of, and IFNα production by, pDCs in rejection 
biopsies compared to biopsies without rejection, and whether activated pDCs can be 
detected in close proximity of infected cells. 
With the identification of GM-CSF as one of the active compounds within HCM, it is 
of interest to note that the prototypic pDC cytokine receptor IL-3 receptor-α (CD123), 
together with IL-5 receptor-α (CD125), belongs to the same receptor family as the GM-CSF 
receptor-α (CD116) 37. Although IL-3 is known to act as a potent survival factor for pDCs, its 
expression within peripheral tissues is restricted 38,39. In contrast, GM-CSF is produced in 
(inflamed) tissues, as well as by activated leukocytes 40,41, suggesting GM-CSF is of 
importance for pDC function in peripheral tissues. The data presented here, together with 
the central role of GM-CSF as a potentiating cytokine for multiple cells of the myeloid 
compartment could position GM-CSF as a key player in mediating alloimmunity. Being 
essential in de initiation of allogeneic immune responses 42, inhibiting APC activation by 
targeting GM-CSF could therefore be instrumental.  
In conclusion, we have shown that renal epithelial cells produce GM-CSF and 
additional, currently unknown, soluble factors, which induce pDC maturation, pro-
inflammatory cytokine production and potently induce their phagocytic capacity upon TLR9 
ligation by CMV-infected AC or CpG. HCCM-activated pDCs subsequently increase indirect Ag 
presentation and are capable of robustly activating CD4+ and CD8+ T cells. Our data therefore 
point to pDCs as potent APC capable of orchestrating allogeneic immune responses, and 






pDC isolation and cell lines 
Ficoll density separation was used to isolate peripheral blood mononuclear cells (PBMC) 
from buffy coats of healthy individuals, which were obtained after informed consent 
(Sanquin, The Netherlands). pDCs were purified from freshly isolated PBMC by negative 
MACS selection, using the Plasmacytoid dendritic cell isolation kit II following manufacturers 
protocol (Miltenyi Biotec, The Netherlands). pDC purity was assessed by flow cytometry 
(LSRII, BD Biosciences) using BDCA-2 FITC and CD123 PE (BD Biosciences), which exceeded 
90% in all cases.  
Human kidney proximal tubular epithelial (HK2) cells were cultured in DMEM HAM 
F12 (Lonza, The Netherlands), supplemented with Tri-iodo thyronine (Sigma), ITS-X (insulin-
transferrin-selenium-ethanolamine, Gibco), Epidermal growth factor (Sigma), Hydrocortison 
(Sigma) and 100 U/mL Penicillin-Streptomycin (Gibco). 
Human ECRF endothelial cells were cultured in medium 199 (Gibco), supplemented 
with 20% FCS, 10 U/mL heparin (LEO Pharma, Canada), 1 tube (25 mg) bovine pituitary gland 
extract (Life Technologies) and 100 U/mL Penicillin-Streptomycin (Gibco). 
All cell lines were regularly tested negative for Mycoplasm infection. 
 
Induction of cell death 
Apoptosis was induced by harvesting HK2 or ECRF cells and subsequent culture in the 
presence of 8 µM H2O2. Alternatively, HK2 cell apoptosis was induced by 400 J/m2 UV-
irradiation. After 48 hours >95% of the apoptotic HK2 cells were secondary necrotic (Annexin 
V and 7AAD positive), which was assessed by flow cytometric analysis of Annexin A5-FITC 
(VPS Diagnostics, The Netherlands) and 7AAD (BD Biosciences) staining. Necrosis was 
induced by heating the cells to 56 °C for 1hr, after which all cells were 7AAD positive. The 
necrotic cells were washed and used directly. 
 
Cytomegalovirus infection and conditioned medium 
HK2 or ECRF cells were cultured overnight to ~80% confluence, after which the culture 
medium was removed and the cells were infected with human CMV TB40-GFP 43 at a MOI of 
100 – 200. To enhance infection, cells were centrifuged at 37 °C for 1 hour at 500 x g. After 
48 – 72 hours of culture, the conditioned medium was harvested, centrifuged at 3500 x g, 
and the supernatant was stored at -20 °C for further use. The infection efficiency was 





pDC and HK2 culture supernatants were analyzed for IFNα (pan IFNα, Mabtech, detection 
limit 30 pg/mL) or IL-3 (Peprotech, detection limit 30 pg/mL) production using a sandwich 
ELISA. All other cytokines and chemokines were determined using Luminex (Bio-rad, 
detection limit <10 pg/mL). 
 
Phagocytosis assay 
AC were isolated, labeled with 4μM CFSE (Thermo Fisher), and washed once with serum-
containing medium. The CFSE labelling was left to settle for at least one hours, after which 
the AC were washed and used for phagocytosis experiments. Fresh pDCs were cultured with 
AC at a 1:1 ratio and the number of pDCs positive for CFSE was determined using flow 
cytometry, after overnight culture at 4 °C versus 37 °C.  
 
Indirect antigen presentation 
Indirect Ag presentation was assessed using CD4+ T cell clone 4.44, which recognizes the 
aa101-114 epitope of HLA-A*201 in the context of HLA-DRB1*0101 44. To this end, 2 * 104 
pDCs (HLA-A2neg, HLA-DRB1*0101pos) were loaded with an aa91-120 HLA-A*201 synthetic 
long peptide (SLP) in the presence of different stimuli. After overnight loading and 
activation, pDCs were washed and CD4+ T cell clone 4.44 was added at a 1:1 ratio. 
Supernatants were harvested after 24 hours and IFNγ production was analyzed by ELISA 
(eBioscience). 
 
Mixed leukocyte reaction  
Peripheral blood lymphocytes (PBL) were isolated by CD14 MACS depletion (Miltenyi Biotec) 
of fresh PBMC, and were labeled with 1 μM CFSE (Thermo Fisher). Allogeneic pDCs were 
activated overnight, washed and subsequently co-cultured with 1 * 105 PBL at pDC:PBL 
ratio’s ranging from 1:10 to 1:40. After 5 days, culture supernatants were isolated and 
stored at -20 °C for Luminex analysis (Bio-rad). T cell proliferation was assessed by analyzing 
the CFSE dilution on viable CD3/4+ CD3/8+ T cells by flow cytometry (LSR-II, BD Biosciences). 
 
Cytokine supplementation and neutralization 
Recombinant cytokines alone, or combined with CpG, were supplemented to pDC cultures at 
the maximum concentrations detected in the conditioned medium, i.e. IL-6 (10 ng/mL, R&D 
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systems), IL-8 (20 ng/mL, eBioscience), GM-CSF (800 pg/mL, Miltenyi Biotec), G-CSF (12 
ng/mL, R&D systems), MCP-1 (300 pg/mL, R&D systems), TNFα (100 pg/mL, Biolegend) and 
IFNγ (75 pg/mL, Peprotech). In order to neutralize GM-CSF, α-GM-CSF (clone # 3209, R&D 
systems) was added to HCM or 500 pg/mL recombinant GM-CSF (Peprotech) at 5 µg/mL 1 
hour prior to use. After overnight culture in the presence of CFSE-labelled AC, phagocytosis 
was analysed using flow cytometry. 
 
Statistical analysis 
Statistical analysis was performed using a paired Student’s t-test, or an one-way ANOVA with 
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Figure 1: CpG-mediated pDC phenotypic maturation and IFNα production are 
enhanced following co-culture with renal epithelial cells 
(A) pDCs were cultured in the presence (black bars) or absence (white bars) of viable HK2 
cells, after which cell surface expression of CD86, CD83 and PD-L1 was determined by flow 
cytometry and (B) IFNα production by ELISA. <: Cytokine levels <10 pg/mL. (C) pDCs were 
cultured in absence (white bars) or presence (black bars) of viable HK2 cells and 
subsequently activated with CpG. The expression of cell surface markers was assessed by 
flow cytometry and (D) IFNα production by ELISA. n = 6; * p < 0.05, ** p = < 0.01; Student’s t-
test. (E) HK2 cells were infected with a GFP-expressing CMV strain (MOI 200), after which 





Figure 2: pDC maturation and cytokine production is increased by conditioned medium of 
CMV-infected HK2 cells 
(A) Representative flow cytometry plots of pDCs cultured with HCM (light grey) or HCCM 
(dark gray) for 48 hours. The line represents the mean value of unstimulated pDCs. (B) 
Quantification of pDC phenotype after culture with HCM or HCCM. (n = 3); ** p = < 0.01; 
Student’s t-test. (C) 48 hour culture supernatants of pDCs cultured in absence or presence of 
HCM or HCCM, were analyzed by Luminex (IL-10 and IL-12p70, n = 3) or ELISA (IFNα, n = 6). * 
p < 0.05; One-way ANOVA. (D) CMV titer of infection medium, HCM and HCCM, as 





Figure 3: Activation by HCCM initiates pDC phagocytic capacity and subsequent maturation 
(A) pDCs were cultured overnight with CFSE-labeled AC in the presence or absence of 
conditioned media, after which BDCA-2 and CD123 positive pDCs were analyzed for CFSE 
positivity by flow cytometry. (B) Quantification of the phagocytosis of AC or CMV-infected 
AC (ACCMV) by pDCs, following overnight culture in the presence of different stimuli (n = 8, 
CMV and ACCMV n = 3). ** p = < 0.01, *** p = < 0.001; One-way ANOVA. (C) Quantification of 
pDC phagocytosis of AC, following culture at 4 °C (white bars) or 37 °C (black bars, n = 2). (D) 
Confocal imaging of pDC were cultured overnight with CFSE-labeled AC (green) in the 
presence of HCCM and subsequently labeled with BDCA-2 and CD123 (red). (E) HLA-A2 
negative pDCs (upper histogram, light grey graph) were cultured overnight with CFSE-
labeled, HLA-A2 positive AC (upper histogram, dark grey graph) in the presence of HCCM. 
Next, CFSE-positivity and HLA-A2 negativity was assessed by flow cytometry (lower plot) as a 
measure for internalization. 
(E) Phenotypic analysis of pDCs by flow cytometry, following overnight culture with AC and 
HCCM. Expression ratio of pDCs which had (+) or had not (-) taken up AC. n = 3; * p = < 0.05, 





Figure 4: HCCM-induced pDC phagocytosis is independent of the type of cell death or 
apoptotic cell source, and enhances indirect antigen presentation 
 (A) Phagocytosis of UV-irradiated HK2 epithelial AC or H2O2-induced ECRF endothelial AC, 
after overnight culture with no stimulus, HCM, or HCCM. n = 1 (B) Phagocytosis of AC or 
necrotic cells (Nec), after overnight culture in the presence of HCM or HCCM, at 4 °C (white 
bars) versus 37 °C (black bars). n = 1 (C) 72-hour conditioned medium of non-infected (ECM) 
or CMV-infected endothelial ECRF cells (ECCM) was added to pDCs and AC. After overnight 
culture, phagocytosis was determined by flow cytometry. n = 1 (D) Under similar conditions, 
pDC phagocytosis was assessed when cultured in the presence of conditioned medium 
derived from non-infected (- CMV) or infected (+ CMV) primary tubular epithelial cells (PTEC) 
. n = 3; * p = < 0.05; Student’s t-test. (E) IFNy production by T cell clone 4.44, after 24 hour 
co-culture with pDCs that were loaded with an 30-mer HLA-A2 SLP in absence of any stimuli, 





Figure 5: CD4+ and CD8+ T cell proliferation and T cell cytokine production is increased by 
HCCM-activated pDCs  
pDCs were activated overnight with different stimuli, washed, and subsequently cultured 
with CFSE-labelled allogeneic peripheral blood lymphocytes, at pDC:PBL ratios of 1:10, 1:20 
or 1:40. (A) After 5 days, CFSE dilution of viable CD4+ and CD8+ T cells (CD3+/7AAD-) was 
assessed by flow cytometry as a measure of T cell proliferation (ratio 1:20). (B) 
Representative example of T cell proliferation following co-culture at different ratios with 
unstimulated pDCs, or pDCs cultured in the presence of HCM or HCCM. (C) Quantification of 
T cell proliferation at a pDC:PBL ratio of 1:20. n = 8; ** p = < 0.01, *** p = < 0.001; One-way 
ANOVA. (D) After 5 days of co-culture, supernatants were analyzed by Luminex, for the 





Figure 6: Infection of HK2 cells is not a prerequisite for the induction of phagocytosis, but the 
combined activation of soluble factors and a TLR9–ligand is. 
(A) HK2 cells were cultured without infection (white bars) or infected with CMV (black bars), 
after which the produced soluble factors were assessed by ELISA (IL-3 and IFNα) or Luminex 
after 72 hours. (n = 2); <: Cytokine levels <15 pg/mL. (B) Phagocytosis induced by the single 
or combined activation of pDCs by TLR9-ligands (ACCMV or CpG) or conditioned medium 
(HCCM or HCM). n = 1 (C) The single or combined activation of pDCs by conditioned medium 
derived from multiple primary tubular epithelial cells (PTCM) and CpG. (D) Analysis of the 
effect of the cytokines detectable in conditioned medium alone (white bars) or combined 
with CpG (Black bars).(E) GM-CSF neutralization by either an isotype antibody, or GM-CSF 
neutralizing antibody, where the phagocytosis induced in the presence of an isotype 
antibody was set to 1. GM-CSF was neutralized in either 500 pg/mL recombinant GM-CSF 
(recGM-CSF, left graph), or HCM (mean GM-CSF concentration 172 pg/mL; right graph). n = 
4; * p = < 0.05, ** p = < 0.01;  One-way ANOVA. 
